surpass tirzepatide Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial Latest Data From SURPASS Trials

Some individuals respond rapidly, while others experience gradual but steady change

Since semaglutide is effective in promoting weight loss and improving metabolic health, it could offer added benefits to epilepsy patients who are overweight or have type 2 diabetes

[DOI] [PMC free article] [PubMed] [Google Scholar] 207.Shang C., et al

A monthly prescription typically runs $179$499

Refrigerator Access : If you travel frequently, ensure your new injection day aligns with when you will have consistent access to refrigeration for storing unopened pens, as Semaglutide pens need to be refrigerated until first use

Post-Translational Modifications (PTMs): Many therapeutic peptides undergo PTMs (e.g., amidation, glycosylation) that impact their biological activity